Addressing antibiotic abuse in China: An experimental audit study

Abstract

China has high rates of antibiotic abuse and antibiotic resistance but the causes are still a matter for debate. Strong physician financial incentives to prescribe are likely to be an important cause. However, patient demand (or physician beliefs about patient demand) is often cited and may also play a role. We use an audit study to examine the effect of removing financial incentives, and to try to separate out the effects of patient demand. We implement a number of different experimental treatments designed to try to rule out other possible explanations for our findings. Together, our results suggest that financial incentives are the main driver of antibiotic abuse in China, at least in the young and healthy population we draw on in our study.

Antibiotic misuse among university students in developed and less developed regions of China: a cross-sectional survey

“…A review of antibiotic use in China demonstrated that 80% of inpatients and 50.3% of outpatients were prescribed with antibiotics, and as many as 75% of patients with seasonal influenza were treated with antibiotics [11]. With one-fifth of the world’s population living in China, this is a serious global concern.…”

Intended And Unintended Consequences Of China’s Zero Markup Drug Policy

“…[10][11][12] The average number of prescriptions per encounter at township health centers has been reported to be 43-150 percent more than the standard recommended by the World Health Organization for outpatients in developing countries and could contribute to antibiotic resistance. 13,14 Moreover, insurance rates have risen over the past decade, 15 and people with insurance are more likely than others to receive inappropriate prescriptions. 16 To address these problems, in April 2009 China introduced its national essential drug list, with the goal of promoting the availability, safety, and appropriate use of essential drugs while reducing excessive household spending on clinically unnecessary medicines.…”

The analysis of the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection

“…Types of responsible pathogens are complicated and in most of the case is mainly Gram negative bacterium. Incidences of complex infection have gradually increased day by day because of antibiotics abuse (Hur et al, 2012;Chidambaram, 2014;Currie et al, 2014). So, to overcome these difficulties, we have to treat them from all kinds of aspects by analyzing.…”